- ►annals.org [PDF] X Zheng, AM Pallera, LT Goodnough, JE … - Annals of internal medicine, 2003 - Am Coll Physicians Remission of Chronic Thrombotic Thrombocytopenic Purpura after ... Xinglong
Zheng, MD, PhD; Arnel M. Pallera, MD; Lawrence T. Goodnough, MD; J. Evan Sadler,
MD, PhD; and Morey A. Blinder, MD ... Background: Thrombotic ... Cited by 92 - Related articles - BL Direct - All 7 versions
J Chemnitz, A Draube, C Scheid, P Staib, A … - American journal of hematology, 2002 - interscience.wiley.com The only established treatment for patients with thrombotic thrombocytopenic
purpura (TTP) is plasma exchange against fresh frozen plasma. For cases
refractory to plasma exchange, no generally treatment schedule exists. One ... Cited by 86 - Related articles - BL Direct - All 4 versions
LA Gutterman, B Kloster, HM Tsai - Blood Cells, Molecules and Diseases, 2002 - Elsevier While most patients of thrombotic thrombocytopenic purpura (TTP) respond to
plasma exchange and achieve remission, a subset of the patients experience
multiple relapses or develop a persistent disease that may be debilitating ... Cited by 76 - Related articles - BL Direct - All 4 versions
HM Tsai, K Shulman - European journal of haematology, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 66 - Related articles - BL Direct - All 4 versions
R Yomtovian, W Niklinski, B Silver, R Sarode, … - British journal of haematology, 2004 - interscience.wiley.com Deficiency of von Willebrand factor (VWF) cleaving protease ADAMTS13 has been
demonstrated to be the proximate cause of a subset of thrombotic
microangiopathic haemolytic anaemias (MAHA) typical for thrombotic ... Cited by 97 - Related articles - BL Direct - All 5 versions
A Ahmad, A Aggarwal, D Sharma, HP Dave, V … - American journal of hematology, 2004 - interscience.wiley.com Plasma exchange is the standard treatment for thrombotic thrombocytopenic
purpura (TTP). For patients refractory to plasma exchange, treatment options are
limited and often unsuccessful. The platelet thrombi that form in acquired ... Cited by 48 - Related articles - BL Direct - All 3 versions
GY Stein, A Zeidman, Z Fradin, M Varon, A … - International journal of hematology, 2004 - Springer Thrombotic thrombocytopenic purpura (TTP) is charac- terized by arteriolar
lesions in various organs that contain platelet thrombi resulting in
thrombocytopenia and microan- giopathic hemolytic anemia due to red blood ... Cited by 18 - Related articles - BL Direct - All 5 versions
PS Reddy, D Deauna-Limayo, JD Cook, SS … - Annals of hematology, 2005 - Springer Abstract Several reports have defined nonfamilial throm- botic thrombocytopenic
purpura (TTP) as an autoimmune disorder caused by antibodies to von Willebrand's
factor- cleaving protease (vWF-CP). This raises the possibility that ... Cited by 48 - Related articles - All 4 versions
NA Aqui, SH Stein, BA Konkle, CS Abrams, FJ … - Journal of Clinical Apheresis, 2003 - interscience.wiley.com Thrombotic thrombocytopenic purpura (TTP) was once uniformly fatal. Therapeutic
plasma exchange in combination with immunosuppressive and anti-platelet agents,
however, have resulted in improved survival rates of greater than 80% for ... Cited by 35 - Related articles - BL Direct - All 3 versions
S Sallah, A Husain, JY Wan, NP Nguyen - Journal of Thrombosis and Haemostasis, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 28 - Related articles - BL Direct - All 4 versions
